XML 74 R61.htm IDEA: XBRL DOCUMENT v3.6.0.2
Shareholders' Equity (Stock Options) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Unrecognized compensation cost $ 18.8    
Weighted average period costs expected to be recognized (in years) 3 years 2 months 13 days    
Stock Options and Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant date fair value of Stock options & SARs (in dollars per share) $ 8.61 $ 11.37 $ 13.40
Expected stock price volatility (percent) 26.88% 25.96% 34.85%
Risk-free interest rate (percent) 1.45% 1.49% 1.53%
Expected annual dividend yield (percent) 2.10% 1.55% 1.80%
Expected term of option & SARs (in years) 5 years 11 months 26 days 5 years 8 months 12 days 6 years 4 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Number of shares, Outstanding at December 31, 2015 920    
Number of shares, Granted 1,001    
Number of shares, Forfeited (93)    
Number of shares, Exercised (75)    
Number of shares, Outstanding at December 31, 2016 1,753 920  
Number of shares, Exercisable 340    
Number of shares, Stock options & SARs expected to vest 1,414    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Weighted average exercise price, Outstanding at December 31, 2015 (in dollars per share) $ 43.47    
Weighted average exercise price, Granted (in dollars per share) 39.99    
Weighted average exercise price, Forfeited (in dollars per share) 46.78    
Weighted average exercise price, Exercised (in dollars per share) 23.55    
Weighted average exercise price, Outstanding at December 31, 2016 (in dollars per share) 42.16 $ 43.47  
Exercisable, Weighted Average Exercise Price (in dollars per share) 37.96    
Stock options & SARs expected to vest, Weighted Average Exercise Price (in dollars per share) $ 43.17    
Weighted average remaining contractual term, options outstanding (in years) 8 years 12 days    
Weighted average remaining contractual term, options exercisable (in years) 4 years 9 months 7 days    
Aggregate intrinsic value, options outstanding $ 7.5    
Aggregate intrinsic value, options exercisable 3.2    
Aggregate intrinsic value $ 1.4 $ 2.8 $ 10.7
Restricted Stock Units (RSUs) and Performance Share Units (PSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Number of shares, Outstanding at December 31, 2015 353    
Number of shares, Granted 83    
Number of shares, Vested (110)    
Number of shares, Forfeited (29)    
Number of shares, Outstanding at December 31, 2016 297 353  
Share-based Compensation Arrangement by Share-based Payment Award, Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average grant date fair value, Outstanding at December 31, 2015 (in dollars per share) $ 41.23    
Weighted average grant date fair value, Granted (in dollars per share) 40.27 $ 45.75 $ 43.21
Weighted average grant date fair value, Vested (in dollars per share) 43.16    
Weighted average grant date fair value, Forfeited (in dollars per share) 39.62    
Weighted average grant date fair value, Outstanding at December 31, 2016 (in dollars per share) $ 41.01 $ 41.23  
Total fair value of shares vested $ 4.7 $ 6.0 $ 11.6